BioPharma

Top, Down... Bottom, up. Middle what? Mass spectrometry meets characterization demands in a new era of Biopharmaceuticals. Learn about applications and ideas paving the way to faster biopharmaceuticals. The emergence of biopharmaceuticals to effectively tackle disease marks a new era in the drug industry— one where responsible, safety-driven production of medicines builds on detailed knowledge about bioprocesses and the compounds they generate. Mass spectrometry offers the analysis depth to propel the industry forward.
December 7, 2016

No longer unknown – novel cytochrome c oxidase subunit revealed

A few years ago, researchers solved the structure of the cbb3-1 cytochrome c oxidase from Pseudomonas stutzeri. They were surprised to detect the presence of a […]
November 8, 2016

Unraveling the complexities of glycoconjugate vaccines

Polysaccharides on the surfaces of bacteria and parasites are targets for the development of pathogen-specific vaccinations, but the purified glycans themselves are poorly immunogenic. Coupling a […]
October 5, 2016

A different way to treat allergies…and allergens

Allergic diseases affect about one third of the world’s population and are increasing in prevalence, particularly among children. Many patients receive allergen immunotherapy (also known as […]
August 4, 2016

New tools in the box: meeting challenges in Biotherapeutics

Protein pharmaceuticals are the fastest growing class of novel therapeutic and diagnostic agents, and a major focus in biopharmaceutical product development. Compared to small molecule drugs, […]
parallax background

Learn more on the latest developments
in Biotherapeutics



Read Article